Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach pain on Wegovy is very common, particularly in the first few weeks of treatment or after a dose increase. It usually arrives as cramping, bloating or a dull ache in the upper abdomen, driven by the way semaglutide slows how quickly food leaves the stomach. For most people, the discomfort is mild and settles within days. It can feel unsettling, but that doesn't make it dangerous. Wegovy is a prescription-only medicine, and any persistent or severe stomach pain should be discussed with your prescriber, who can help you work out what's causing it and whether anything needs to change.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors in the gut and brain. One of its direct effects is slowing gastric emptying, the rate at which your stomach pushes food into the small intestine. That slowdown is part of why Wegovy reduces appetite so effectively. It also explains why stomach pain, bloating and nausea tend to cluster together: when food lingers longer than usual, pressure builds, and the stomach's muscular walls respond with cramping.
On top of that, semaglutide affects gut motility more broadly, which is why some people on Wegovy also notice loose stools, constipation or both at different points in treatment. If you want a clearer picture of the underlying mechanism, the semaglutide overview on our site explains how the medicine works and what the clinical evidence shows.
The NHS medicines page for semaglutide lists abdominal pain among the common side effects, alongside nausea, vomiting, diarrhoea and constipation. Common in this context means it affects roughly one in ten people or more. In practice, many patients experience at least one of these GI effects at some point, particularly in the opening weeks of treatment or around dose changes. Knowing that in advance makes it easier to ride it out rather than panic at the first twinge. That said, not every stomach ache during treatment is caused by the medicine, and severity matters enormously. The next two steps cover both.
For broader context on how Wegovy is used in the UK (including eligibility and how it fits into a structured weight management plan) the Wegovy treatment page is a good starting point.
The pattern most people describe is a crampy, sometimes bloated ache around the upper abdomen. It can come on during a meal if you've eaten too quickly or too much, or linger for an hour or two afterwards. Some people describe it as pressure; others as an unsettled, queasy heaviness. Injection-site discomfort sits separately from this and should not be confused with internal abdominal pain, if you're unsure where Wegovy is actually injected and what's normal at the site, the page on Wegovy injections in the stomach area covers that clearly.
In terms of timing, stomach pain on Wegovy tends to be worst in the days immediately after a new pen or a dose increase. The 0.25mg starting dose is the tolerability step, the one that's there to let your body adjust before the therapeutic doses begin. Most people find discomfort peaks somewhere in that first week and then gradually softens. By week three or four at a given dose level, the gut has usually adapted enough that meals feel normal again, at least until the next dose step.
A small number of people find that eating anything rich, fatty or in large portions reliably triggers cramping throughout their time on treatment. Eating the way most of us manage on a busy Tuesday (too fast, too much, standing over the hob) makes things noticeably worse. Slowing down and halving portions is often more effective than any supplement.
You can read about stomach pains on Wegovy in more depth, including how the experience changes across different dose levels.
Most Wegovy-related stomach pain is mild and self-limiting. Some is not, and it matters to know the difference before it escalates.
In January 2026, the MHRA published a Drug Safety Update specifically on GLP-1 receptor agonist medicines, highlighting acute pancreatitis as an infrequent but potentially serious risk. The symptom to act on immediately is severe, persistent pain in the upper abdomen that spreads toward the back, it may or may not come with vomiting. If that describes what you're feeling, stop eating and drinking and get urgent medical help rather than waiting for your next prescriber review. This is the scenario that changes the equation from "expected side effect" to "requires same-day assessment".
Other symptoms that warrant a prompt call to your GP or prescriber include pain accompanied by signs of dehydration (dark urine, dizziness, inability to keep fluids down for more than a few hours) or sudden worsening of pain that doesn't match the usual post-meal pattern. You can also report unexpected side effects directly through the MHRA Yellow Card scheme, which helps regulators monitor the safety of medicines in real-world use.
Semaglutide-related stomach pain relief, including which foods and habits genuinely help, is covered on our dedicated semaglutide stomach pain relief page. And if your symptoms feel more like a sudden gastric illness than the usual adjustment period, the comparison on our Wegovy stomach flu page may help you tell the two apart.
If you're already on Wegovy and finding side effects hard to manage, reaching out to your prescriber is always the right move. For those earlier in the process who are considering treatment and want to understand what supervised, clinically reviewed care looks like, checking your eligibility with our prescribers costs nothing and takes a few minutes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.